meclofenamic acid has been researched along with Bladder Cancer in 1 studies
Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kovala-Demertzi, D | 1 |
| Staninska, M | 1 |
| Garcia-Santos, I | 1 |
| Castineiras, A | 1 |
| Demertzis, MA | 1 |
1 other study available for meclofenamic acid and Bladder Cancer
| Article | Year |
|---|---|
Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cadmium; Cell Line, Tumor; Chelating Agents; Coord | 2011 |